Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients
- PMID: 26377489
- DOI: 10.1007/s11255-015-1107-9
Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients
Abstract
In the last decade, an increasing number of patients over 75 years of age are starting renal replacement therapy. Frailty is highly prevalent in elderly patients with end-stage renal disease (ESRD) in the context of the increased prevalence of some ESRD-associated conditions: protein-energy wasting, inflammation, anaemia, acidosis or hormonal disturbances. There are currently no hard data to support guidance on the optimal duration of dialysis for frail/elderly ESRD patients. The current debate is not about starting dialysis or managing conservatory frail ESRD patients, but whether a more intensive regimen once dialysis is initiated (for whatever reasons and circumstances) would improve patients' outcome. The most important issue is that all studies performed with extended/alternative dialysis regimens do not specifically address this particular type of patients and therefore all the inferences are derived from the general ESRD population. Care planning should be responsive to end-of-life needs whatever the treatment modality. Care in this setting should focus on symptom control and quality of life rather than life extension. We conclude that, similar to the general dialysed population, extensive application of more intensive dialysis schedules is not based on solid evidence. However, after a thorough clinical evaluation, a limited period of a trial of intensive dialysis could be prescribed in more problematic patients.
Keywords: Dialysis; Elderly; Frail.
Similar articles
-
High prevalence of frailty in end-stage renal disease.Int Urol Nephrol. 2016 Aug;48(8):1357-1362. doi: 10.1007/s11255-016-1306-z. Epub 2016 May 10. Int Urol Nephrol. 2016. PMID: 27165401 Free PMC article.
-
Frailty in End-Stage Renal Disease Patients under Dialysis and Its Association with Clinical and Biochemical Markers.J Frailty Aging. 2017;6(2):103-106. doi: 10.14283/jfa.2017.14. J Frailty Aging. 2017. PMID: 28555712
-
End-Stage Kidney Disease in the Elderly: Approach to Dialysis Initiation, Choosing Modality, and Predicting Outcomes.Adv Chronic Kidney Dis. 2016 Jan;23(1):36-43. doi: 10.1053/j.ackd.2015.08.005. Adv Chronic Kidney Dis. 2016. PMID: 26709061 Review.
-
Can quality of life be improved for the increasing numbers of older patients with end-stage kidney disease?Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):661-6. doi: 10.1586/erp.10.78. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 21155699 Review.
-
Frailty and mortality in dialysis: evaluation of a clinical frailty scale.Clin J Am Soc Nephrol. 2015 May 7;10(5):832-40. doi: 10.2215/CJN.07760814. Epub 2015 Mar 4. Clin J Am Soc Nephrol. 2015. PMID: 25739851 Free PMC article.
Cited by
-
Living with frailty and haemodialysis: a qualitative study.BMC Nephrol. 2022 Jul 22;23(1):260. doi: 10.1186/s12882-022-02857-w. BMC Nephrol. 2022. PMID: 35869436 Free PMC article.
-
No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.Am J Nephrol. 2018;48(5):389-398. doi: 10.1159/000494336. Epub 2018 Nov 13. Am J Nephrol. 2018. PMID: 30423584 Free PMC article.
-
Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults.Int Urol Nephrol. 2016 Jun;48(6):859-69. doi: 10.1007/s11255-016-1257-4. Epub 2016 Mar 17. Int Urol Nephrol. 2016. PMID: 26984833
-
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Nat Rev Nephrol. 2017 Jul;13(7):393-409. doi: 10.1038/nrneph.2017.63. Epub 2017 May 30. Nat Rev Nephrol. 2017. PMID: 28555652 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
